Is there potential for growth in Brazil's phytotherapic drug market?
Brunei harnesses its rich biodiversity and the growing halal market in a bid to develop its pharmaceutical sector.
China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.
Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.
Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R'D, clinical research, and market growth.